|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WLY012324663 |
| 003 |
DE-627 |
| 005 |
20230308000041.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
230220s2021 xx |||||o 00| ||und c |
| 024 |
7 |
|
|a 10.1111/pim.12840
|2 doi
|
| 028 |
5 |
2 |
|a PIM_PIM12840.xml
|
| 035 |
|
|
|a (DE-627)WLY012324663
|
| 035 |
|
|
|a (WILEY)PIM12840
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 082 |
0 |
4 |
|a 590
|q ASE
|
| 084 |
|
|
|a 42.00
|2 bkl
|
| 100 |
1 |
|
|a Muñoz‐Carrillo, José Luis
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Resiniferatoxin promotes adult worm expulsion in Trichinella spiralis‐infected rats by Th2 immune response modulation
|
| 264 |
|
1 |
|c 2021
|
| 300 |
|
|
|a 16
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Copyright © 2021 John Wiley & Sons Ltd
|
| 520 |
|
|
|a Abstract Background The immune response during T spiralis infection is characterized by an increase in eosinophils and mast cells, as well as Th2 cytokine production, such as interleukin (IL)‐4, IL‐10 and IL‐13, promoting T spiralis expulsion from the host. However, this response damages the host, favouring the parasite survival. In the search for new pharmacological strategies that protect against T spiralis infection, a recent study showed that treatment with resiniferatoxin (RTX) modulates the Th1 cytokines production, reducing muscle parasite burden. Objective To evaluate the effect of RTX treatment on the Th2 cytokines production, the number of eosinophils, mast cells and the intestinal expulsion of T spiralis. Methods Serum levels of IL‐4, IL‐10 and IL‐13 were quantified by ELISA; the number of eosinophils, mast cells and the adult worms of T spiralis in the small intestine was quantified. Results RTX treatment increased serum levels of IL‐4, IL‐10 and IL‐13, and it decreases intestinal eosinophilia, however, favours the mastocytosis, promoting T spiralis intestinal expulsion. Conclusions These findings suggest that RTX is capable to modulate the Th2 immune response, promoting T spiralis expulsion, which contributes to the defence against T spiralis infection, placing the RTX as a potential immunomodulatory drug.
|
| 700 |
1 |
|
|a Gutiérrez‐Coronado, Oscar
|4 aut
|
| 700 |
1 |
|
|a Muñoz‐Escobedo, José Jesús
|4 aut
|
| 700 |
1 |
|
|a Contreras‐Cordero, Juan Francisco
|4 aut
|
| 700 |
1 |
|
|a Maldonado‐Tapia, Claudia
|4 aut
|
| 700 |
1 |
|
|a Moreno‐García, María Alejandra
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Parasite Immunology
|g 43(2021), 8
|w (DE-627)WLY012322709
|x 13653024
|7 nnns
|
| 773 |
1 |
8 |
|g volume:43
|g year:2021
|g number:8
|g extent:16
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_WLY
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_110
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_206
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_618
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2009
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 912 |
|
|
|a GBV_ILN_2035
|
| 912 |
|
|
|a GBV_ILN_2105
|
| 936 |
b |
k |
|a 42.00
|q ASE
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 43
|j 2021
|e 8
|g 16
|